Zymeworks (ZYME) EBIT Margin (QoQ) (2021 - 2026)
Powered by 
Analysis
Zymeworks (ZYME) EBIT Margin (QoQ) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn |
| 10 | Zymeworks | 2.15 Bn | 1.88 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 103,777.00 |
| Mar 31, 2026 | -20,118.00 |
| Dec 31, 2025 | -167,548.00 |
| Sep 30, 2025 | -7,868.00 |
| Jun 30, 2025 | 9,309.00 |
| Mar 31, 2025 | -2,288.00 |
| Dec 31, 2024 | 14,219.00 |
| Sep 30, 2024 | 908.00 |
| Jun 30, 2024 | 15,402.00 |
| Mar 31, 2024 | -23,852.00 |
| Dec 31, 2023 | 6,299.00 |
| Sep 30, 2023 | 57,147.00 |
| Jun 30, 2023 | -69,616.00 |
| Mar 31, 2023 | -17,495.00 |
| Dec 31, 2022 | 201,230.00 |
| Sep 30, 2022 | -70,449.00 |
| Jun 30, 2022 | 258,410.00 |
| Mar 31, 2022 | -328,302.00 |
| Dec 31, 2021 | 87,651.00 |